PMID: 42253408

Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus.

Sharma Prabhat Kumar, Viswaprasad V, Choudhary Animesh, Nurulhasan Ansari Rizwanahmed, Redkar Sagar Vivek, Bharatkumar Patel Manan, Patil Vijaykumar Shivajirao, Anand Sumit, Barge Vijaykumar, Shah Shalin J

Metabolism open · 2026

Vol. 30, pp. 100476

View on PubMed DOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.